Description

6-Bromo-2-[3-(4-Chlorophenyl)-2,1-benzoxazol-5-yl]quinoline-4-carboxylic acid is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound matters for its critical role as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated molecular scaffolds. Pharmaceutical R&D laboratories and fine chemical manufacturers need this material for developing next-generation drug candidates targeting a range of diseases.

Application

• Pharmaceutical Intermediate: Serves as a crucial precursor in the synthesis of novel drug candidates, particularly in oncology and central nervous system (CNS) therapeutic research.
• Organic Light-Emitting Diode (OLED) Research: Used in the development of electron-transport or emissive layer materials due to its quinoline-based conjugated system.
• Agrochemical Synthesis: Acts as a building block for creating new compounds with potential herbicidal or pesticidal activity.
• Material Science: Investigated for use in the creation of advanced organic semiconductors and photoactive materials.
• Academic & Industrial R&D: Employed in chemical libraries for high-throughput screening and structure-activity relationship (SAR) studies.
• Fluorescent Probe Development: Utilized in the design of sensitive chemical sensors and bio-imaging agents.

Basic Information

Product Name	6-Bromo-2-[3-(4-Chlorophenyl)-2,1-benzoxazol-5-yl]quinoline-4-carboxylic Acid
CAS No.	882141-16-4
Molecular Formula	C25H14BrClN2O3
Molecular Weight	505.75 g/mol
Synonyms	6-Bromo-2-[3-(4-chlorophenyl)benzo[d]oxazol-5-yl]quinoline-4-carboxylic acid; 2,1-Benzoxazole-5-carboxylic acid, 6-bromo-2-[3-(4-chlorophenyl)-2,1-benzoxazol-5-yl]-4-quinoline; 882141-16-4; 6-Bromo-2-(3-(4-chlorophenyl)benzo[d]oxazol-5-yl)quinoline-4-carboxylic acid; Quinoline-4-carboxylic acid, 6-bromo-2-[3-(4-chlorophenyl)-2,1-benzoxazol-5-yl]-
EINECS	Contact for details

Quality Control

Our 6-Bromo-2-[3-(4-Chlorophenyl)-2,1-benzoxazol-5-yl]quinoline-4-carboxylic acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all critical quality attributes. Our commitment to cGMP standards and reliable supply chain integrity makes us a trusted partner for your critical R&D and production needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). The product is light-sensitive (store away from light) and should be handled in accordance with good laboratory practices for strong acid/organic solvents. Keep away from heat, sparks, and open flame.

Specification

Item	Specification
Appearance	Off-white to light yellow powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0%
Single Maximum Impurity	≤ 1.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.